492 related articles for article (PubMed ID: 10585234)
1. Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying.
Sarciaux JM; Mansour S; Hageman MJ; Nail SL
J Pharm Sci; 1999 Dec; 88(12):1354-61. PubMed ID: 10585234
[TBL] [Abstract][Full Text] [Related]
2. Lyophilization-induced protein denaturation in phosphate buffer systems: monomeric and tetrameric beta-galactosidase.
Pikal-Cleland KA; Carpenter JF
J Pharm Sci; 2001 Sep; 90(9):1255-68. PubMed ID: 11745778
[TBL] [Abstract][Full Text] [Related]
3. The effects of formulation variables on the stability of freeze-dried human growth hormone.
Pikal MJ; Dellerman KM; Roy ML; Riggin RM
Pharm Res; 1991 Apr; 8(4):427-36. PubMed ID: 1871037
[TBL] [Abstract][Full Text] [Related]
4. Fundamentals of freeze-drying.
Nail SL; Jiang S; Chongprasert S; Knopp SA
Pharm Biotechnol; 2002; 14():281-360. PubMed ID: 12189727
[TBL] [Abstract][Full Text] [Related]
5. Development of freeze-dried albumin-free formulation of recombinant factor VIII SQ.
Osterberg T; Fatouros A; Mikaelsson M
Pharm Res; 1997 Jul; 14(7):892-8. PubMed ID: 9244146
[TBL] [Abstract][Full Text] [Related]
6. Stability of ribonuclease A in solution and the freeze-dried state.
Townsend MW; DeLuca PP
J Pharm Sci; 1990 Dec; 79(12):1083-6. PubMed ID: 2079655
[TBL] [Abstract][Full Text] [Related]
7. Freeze-drying of tert-butyl alcohol/water cosolvent systems: effects of formulation and process variables on residual solvents.
Wittaya-Areekul S; Nail SL
J Pharm Sci; 1998 Apr; 87(4):491-5. PubMed ID: 9548903
[TBL] [Abstract][Full Text] [Related]
8. The effect of freeze-drying parameters and formulation composition on IgG stability during drying.
Heljo VP; Harju H; Hatanpää T; Yohannes G; Juppo AM
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):752-5. PubMed ID: 23623795
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of protein structure in freeze-dried amorphous organic acid buffer salts.
Izutsu K; Kadoya S; Yomota C; Kawanishi T; Yonemochi E; Terada K
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1231-6. PubMed ID: 19881273
[TBL] [Abstract][Full Text] [Related]
10. Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway.
Barnard JG; Singh S; Randolph TW; Carpenter JF
J Pharm Sci; 2011 Feb; 100(2):492-503. PubMed ID: 20803602
[TBL] [Abstract][Full Text] [Related]
11. A new mechanism for decreasing aggregation of recombinant human interferon-gamma by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20.
Webb SD; Cleland JL; Carpenter JF; Randolph TW
J Pharm Sci; 2002 Feb; 91(2):543-58. PubMed ID: 11835212
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Phosphate Buffered Saline (PBS) in Frozen State and after Freeze-Drying.
Thorat AA; Suryanarayanan R
Pharm Res; 2019 May; 36(7):98. PubMed ID: 31087169
[TBL] [Abstract][Full Text] [Related]
13. Counteracting effects of thiocyanate and sucrose on chymotrypsinogen secondary structure and aggregation during freezing, drying, and rehydration.
Allison SD; Dong A; Carpenter JF
Biophys J; 1996 Oct; 71(4):2022-32. PubMed ID: 8889176
[TBL] [Abstract][Full Text] [Related]
14. Comparing the acidities of aqueous, frozen, and freeze-dried phosphate buffers: Is there a "pH memory" effect?
Vetráková Ľ; Vykoukal V; Heger D
Int J Pharm; 2017 Sep; 530(1-2):316-325. PubMed ID: 28779984
[TBL] [Abstract][Full Text] [Related]
15. Spray-freeze-drying for protein powder preparation: particle characterization and a case study with trypsinogen stability.
Sonner C; Maa YF; Lee G
J Pharm Sci; 2002 Oct; 91(10):2122-39. PubMed ID: 12226840
[TBL] [Abstract][Full Text] [Related]
16. Solute crystallization in mannitol-glycine systems--implications on protein stabilization in freeze-dried formulations.
Pyne A; Chatterjee K; Suryanarayanan R
J Pharm Sci; 2003 Nov; 92(11):2272-83. PubMed ID: 14603512
[TBL] [Abstract][Full Text] [Related]
17. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins I: stability after freeze-drying.
Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G
J Pharm Sci; 2010 May; 99(5):2256-78. PubMed ID: 20039389
[TBL] [Abstract][Full Text] [Related]
18. Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation.
Kolhe P; Amend E; Singh SK
Biotechnol Prog; 2010; 26(3):727-33. PubMed ID: 20039442
[TBL] [Abstract][Full Text] [Related]
19. Glycine crystallization in frozen and freeze-dried systems: effect of pH and buffer concentration.
Varshney DB; Kumar S; Shalaev EY; Sundaramurthi P; Kang SW; Gatlin LA; Suryanarayanan R
Pharm Res; 2007 Mar; 24(3):593-604. PubMed ID: 17245648
[TBL] [Abstract][Full Text] [Related]
20. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
